What is the role of Rotarix in the prevention of bacterial gastroenteritis?

Updated: Jul 17, 2018
  • Author: Jennifer Lynn Bonheur, MD; Chief Editor: BS Anand, MD  more...
  • Print

In April 2008, the FDA approved Rotarix, another oral vaccine, for prevention of rotavirus gastroenteritis. It is currently recommended that Rotarix be administered in 2 separate doses to patients between ages 6 and 24 weeks. Rotarix was efficacious in a large study, which showed that it protected patients with severe rotavirus gastroenteritis and also decreased the rate of severe diarrhea or gastroenteritis from any cause. [27]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!